Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Syngene International's profit after tax surged 59% to Rs 87 crore in Q1 2025, driven by revenue growth and a tax benefit.

With over three decades of experience across India, ASEAN, and Australia, Deepali Naair brings deep expertise in brand ...

Syngene International reported a growth in its profit after tax (before exceptional items) by 61 per cent year-on-year (y-o-y), to ₹87 crore, in Q1 of FY26 as against ₹54 crore in the year-ago period.

Biocon Biologics appoints Deepali Naair as Global Head of Brand & Corporate Communications. She brings 30+ years experience ...

On Wednesday, 2005 stocks advanced, 2025 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...

This article highlights the top B.Tech Biotechnology colleges in India for 2025, detailing their course durations, fees, and ...

Syngene International reported a 61% increase in consolidated profit after tax, reaching Rs 87 crore in Q1 2025. Revenue rose ...

Syngene's margins narrowed on a sequential basis. Apart from margins, Syngene's revenue and EBITDA are also lower by 14.1% ...